65N-18706-58885 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-23
Dose 1 — Moderna
2021-04-01
Registered in v-safe
2021-04-01
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-04-06
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-04-13
Health check-in — day 21, dose 1
Feeling: Good

Adult check-in
2021-04-20
Dose 2 — Moderna
2021-04-20
Health check-in — day 0, dose 2
Feeling: Good · None

Adult check-in
2021-04-21
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-04-22
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Fever · Chills, Headache, Fatigue or tiredness · Be unable to work

Adult check-in
2021-04-23
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-04-24
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-04-25
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-04-26
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-04-27
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-05-04
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-05-11
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-05-18
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-05-25
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-06-01
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-07-22
Survey response — 3 months, dose 2
MedDRA: Immunology test abnormal, Pre-existing disease — Feeling: Good

Free text: I had a flare of an autoimmune disease, pemphigus foliaceus. Actually, I have no symptoms but my anti-desmoglein-1 level has jumped from 11 in Feb 2021 to 44 in June 2021, into the positive range.

MedDRA releases: 2024-11 · check-in free text available
2021-10-19
Survey response — 6 months, dose 2
MedDRA: Pulmonary pain, SARS-CoV-2 test negative — Feeling: Good

Free text: Some lung pain but I had a COVID test and it came back negative.

MedDRA releases: 2024-11 · check-in free text available
2021-11-08
Dose 3 — Pfizer-BioNTech
2022-04-22
Survey response — 12 months, dose 2
MedDRA: Condition aggravated, Pemphigus, Pre-existing disease — Feeling: Good

Free text: Recurrence of lesions due to pemphigus foliaceus, which had been in remission since Jan 2018.

MedDRA releases: 2024-11 · check-in free text available
2022-04-30
Dose 4 — Moderna
2022-05-14
Health check-in — day 14, dose 4
Feeling: Good

Adult check-in
2022-06-06
Survey response — day 35, dose 4
MedDRA: COVID-19, Cough, Fatigue, Headache, SARS-CoV-2 test positive — Feeling: Poor · Be unable to work or attend school

Free text: I have COVID-19 according to a rapid antigen test. Headache, a cough, not too bad but I'm very tired.

MedDRA releases: 2024-11 · check-in free text available
2022-06-11
Health check-in — day 42, dose 4
Feeling: Fair

Adult check-in
2022-07-30
Health check-in — 3 months, dose 4
Feeling: Good

Adult check-in
2022-10-31
Survey response — 6 months, dose 4
MedDRA: Pre-existing disease — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Rituximab treatment for an autoimmune disorder in July 2022

MedDRA releases: 2024-11 · check-in free text available
2022-10-31
Report sent to call center — 6 months, dose 4
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-11-01
Call 1 — Left Voicemail
2023-04-30
Health check-in — 12 months, dose 4
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-23	Moderna
2	2021-04-20	Moderna
3	2021-11-08	Pfizer-BioNTech	No
4	2022-04-30	Moderna	No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 9 — 3 months, dose 2

2021-07-22

Symptoms: I had a flare of an autoimmune disease, pemphigus foliaceus. Actually, I have no symptoms but my anti-desmoglein-1 level has jumped from 11 in Feb 2021 to 44 in June 2021, into the positive range.

Release 10 — 6 months, dose 2

2021-10-19

Symptoms: Some lung pain but I had a COVID test and it came back negative.

Release 11 — 12 months, dose 2

2022-04-22

Symptoms: Recurrence of lesions due to pemphigus foliaceus, which had been in remission since Jan 2018.

Release 11 — day 35, dose 4

2022-06-06

Symptoms: I have COVID-19 according to a rapid antigen test. Headache, a cough, not too bad but I'm very tired.

Release 12 — 6 months, dose 4

2022-10-31

Symptoms: Rituximab treatment for an autoimmune disorder in July 2022

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Condition aggravated	·	·	✓
SD	Cough	·	·	✓
SD	COVID-19	·	·	✓
SD	Fatigue	·	·	✓
SD	Headache	·	·	✓
SD	Immunology test abnormal	·	·	✓
SD	Pemphigus	·	·	✓
SD	Pre-existing disease	·	·	✓
SD	Pulmonary pain	·	·	✓
SD	SARS-CoV-2 test negative	·	·	✓
SD	SARS-CoV-2 test positive	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release